Stada Arzneimittel Aktiengesellschaft Stock Current Valuation
Valuation analysis of STADA Arzneimittel helps investors to measure STADA Arzneimittel's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
STADA Arzneimittel Aktiengesellschaft OTC Stock Current Valuation Analysis
STADA Arzneimittel's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current STADA Arzneimittel Current Valuation | 6.87 B |
Most of STADA Arzneimittel's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, STADA Arzneimittel Aktiengesellschaft is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, STADA Arzneimittel Aktiengesellschaft has a Current Valuation of 6.87 B. This is 52.17% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 58.67% higher than that of the company.
STADA Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses STADA Arzneimittel's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of STADA Arzneimittel could also be used in its relative valuation, which is a method of valuing STADA Arzneimittel by comparing valuation metrics of similar companies.STADA Arzneimittel is currently under evaluation in current valuation category among related companies.
STADA Fundamentals
| Return On Equity | 22.55 | |||
| Return On Asset | 6.39 | |||
| Profit Margin | 9.00 % | |||
| Current Valuation | 6.87 B | |||
| Shares Outstanding | 62.26 M | |||
| Shares Owned By Institutions | 0.30 % | |||
| Price To Earning | 22.46 X | |||
| Price To Book | 4.54 X | |||
| Price To Sales | 2.11 X | |||
| Revenue | 2.69 B | |||
| Gross Profit | 1.37 B | |||
| EBITDA | 559.98 M | |||
| Net Income | 252.03 M | |||
| Cash And Equivalents | 502.02 M | |||
| Cash Per Share | 8.06 X | |||
| Total Debt | 1.73 B | |||
| Debt To Equity | 2.58 % | |||
| Current Ratio | 1.49 X | |||
| Book Value Per Share | 20.02 X | |||
| Cash Flow From Operations | 347.14 M | |||
| Earnings Per Share | 4.05 X | |||
| Number Of Employees | 12.34 K | |||
| Beta | 0.35 | |||
| Market Capitalization | 6.87 B | |||
| Total Asset | 3.46 B | |||
| Retained Earnings | 686 M | |||
| Working Capital | 604 M | |||
| Current Asset | 1.49 B | |||
| Current Liabilities | 887 M | |||
| Z Score | 1.8 | |||
| Last Dividend Paid | 0.11 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards STADA Arzneimittel in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, STADA Arzneimittel's short interest history, or implied volatility extrapolated from STADA Arzneimittel options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the STADA Arzneimittel information on this page should be used as a complementary analysis to other STADA Arzneimittel's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in STADA OTC Stock
If you are still planning to invest in STADA Arzneimittel check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the STADA Arzneimittel's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |